Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBIT Margin (2021 - 2025)

Tenon Medical has reported EBIT Margin over the past 5 years, most recently at 193.52% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 21856.0% year-over-year to 193.52%; the TTM value through Dec 2025 reached 324.34%, up 9574.0%, while the annual FY2025 figure was 324.34%, 9574.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 193.52% at Tenon Medical, up from 289.17% in the prior quarter.
  • Over five years, EBIT Margin peaked at 193.52% in Q4 2025 and troughed at 7331.82% in Q2 2021.
  • A 5-year average of 1673.29% and a median of 544.13% in 2023 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: tumbled -166817bps in 2022 and later skyrocketed 345979bps in 2023.
  • Year by year, EBIT Margin stood at 4833.96% in 2021, then surged by 41bps to 2862.09% in 2022, then skyrocketed by 86bps to 388.74% in 2023, then fell by -6bps to 412.08% in 2024, then skyrocketed by 53bps to 193.52% in 2025.
  • Business Quant data shows EBIT Margin for TNON at 193.52% in Q4 2025, 289.17% in Q3 2025, and 506.56% in Q2 2025.